Analysis of caffeine and paraxanthine in human saliva with ultra-high-performance liquid chromatography for CYP1A2 phenotyping

Nan Yeun Jordan, Jolet Y. Mimpen, Willie J. M. van den Bogaard, Frits M. Flesch, Michiel H. M. van de Meent, Javier Sastre Torano*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Cytochrome P450 1A2 (CYP1A2) plays an important role in drug metabolism. Caffeine (CAF) is converted into paraxanthine (PX) by this enzyme and is used as a xenobiotic substrate to determine the CYP1A2 phenotype in humans. A method for the quantification of CAF and PX in saliva was developed using liquid-liquid extraction with ethyl acetate and analysis with ultra-high-performance liquid chromatography. Peaks from CAF, PX and internal standard were resolved within 6 min. The method was validated from 0.05 to 5 mu g mL(-1) CAF and 0.025-2.5 mu g mL(-1) PX. Inter- and intra-day accuracies ranged from 91.2 to 107.2% with precisions

Original languageEnglish
Pages (from-to)70-73
Number of pages4
JournalJournal of chromatography. B
Volume995
DOIs
Publication statusPublished - 15 Jul 2015

Keywords

  • Caffeine
  • Paraxanthine
  • CYP1A2
  • Phenotyping
  • Saliva
  • UHPLC
  • IN-VIVO
  • PLASMA
  • THEOPHYLLINE
  • METABOLITES
  • CYP2E1
  • RATIO
  • DRUG

Fingerprint

Dive into the research topics of 'Analysis of caffeine and paraxanthine in human saliva with ultra-high-performance liquid chromatography for CYP1A2 phenotyping'. Together they form a unique fingerprint.

Cite this